Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been given a consensus rating of “Moderate Buy” by the five ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $8.3750.

A number of analysts have recently commented on the company. Oppenheimer cut their price target on Bioceres Crop Solutions from $7.00 to $6.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 15th. Wall Street Zen lowered Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Brookline Capital Management lowered Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a research note on Thursday.

Bioceres Crop Solutions Stock Performance

Shares of BIOX stock opened at $2.93 on Friday. The business’s 50-day moving average price is $3.88 and its 200-day moving average price is $4.34. Bioceres Crop Solutions has a 12 month low of $2.60 and a 12 month high of $11.41. The firm has a market capitalization of $183.74 million, a price-to-earnings ratio of -20.93, a PEG ratio of 1.26 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings results on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a negative return on equity of 2.37% and a negative net margin of 2.14%.The firm had revenue of $59.60 million for the quarter, compared to analyst estimates of $61.80 million. Equities research analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently made changes to their positions in BIOX. JPMorgan Chase & Co. lifted its stake in shares of Bioceres Crop Solutions by 17.0% in the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after acquiring an additional 15,328 shares during the period. Jump Financial LLC acquired a new position in shares of Bioceres Crop Solutions in the fourth quarter worth approximately $72,000. Stifel Financial Corp lifted its stake in shares of Bioceres Crop Solutions by 51.9% in the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company’s stock worth $377,000 after acquiring an additional 21,168 shares during the period. Northern Trust Corp acquired a new position in shares of Bioceres Crop Solutions in the fourth quarter worth approximately $93,000. Finally, Bank of America Corp DE lifted its stake in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after acquiring an additional 3,735 shares during the period. 17.68% of the stock is owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.